跳至主要内容
临床试验/CTRI/2021/01/030300
CTRI/2021/01/030300尚未招募2 期

Intravenous Ketorolac versus intravenous Morphine for the management of severe vaso-occlusive crisis in children with sickle cell disease. A randomized controlled trial.

AIIMSRaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方